Medicine and Dentistry
Hepatitis C Virus
100%
Chronic Hepatitis C
84%
Prevalence
79%
Hepatitis C
74%
Cohort Analysis
61%
Infection
58%
Chronic Hepatitis B
57%
Human Immunodeficiency Virus
56%
Hepatitis B Virus
56%
Cross Sectional Study
51%
Liver Cirrhosis
50%
Hepatocellular Carcinoma
46%
Promoter Region
39%
Hepatitis B
38%
Pancreas Adenocarcinoma
33%
Biological Marker
31%
Cell-Free DNA
30%
Neoplasm
25%
Ribavirin
24%
Population
22%
Diseases
22%
Disease Burden
21%
Liver Disease
20%
Colorectal Cancer
20%
Virus Infection
18%
Mortality Rate
18%
Antiviral Therapy
17%
Hereditary Nonpolyposis Colorectal Cancer
16%
Rapid Test
16%
Circulating Tumor DNA
15%
Decompensated Liver Cirrhosis
14%
Epileptic Absence
13%
Secreted Frizzled-Related Protein 1
13%
Diagnosis
13%
Diabetes
13%
Liver Cancer
12%
Heart Rate Variability
12%
Pancreas Cancer
12%
Proportional Hazards Model
12%
Fibrosis
12%
Peginterferon
11%
Mixed Infection
11%
Arm
10%
Screening
10%
Tuberculosis
10%
Systematic Review
9%
Antiretroviral Therapy
9%
Transient Elastography
9%
Peginterferon Alpha
9%
Liver Biopsy
9%
Biochemistry, Genetics and Molecular Biology
Hepatitis C Virus
74%
Hepatitis B Virus
64%
Genotyping
53%
Prevalence
39%
Cohort Study
36%
Cross Sectional Study
32%
Case-Control Study
27%
Human Immunodeficiency Virus
26%
MSH6
25%
Pribnow Box
20%
Interferon
18%
interferon
18%
Dynamics
16%
Cyclooxygenase
16%
DNA Methylation
16%
Promoter Region
16%
Neutralizing Antibody
16%
Genome-Wide Association Study
16%
Methylation
16%
Ribavirin
16%
HBsAg
15%
Single-Nucleotide Polymorphism
13%
Genetic Screening
13%
Screening
12%
DNA Mismatch Repair
12%
Metabolomics
11%
Metabolome
11%
CD163
10%
Interleukin 28B
10%
Body Mass
10%
Metabolite
10%
Genetics
10%
Liver Biochemistry
9%
Human Immunodeficiency Virus 1
9%
Colon
9%
Hepatitis C Virus Genotype 3
9%
Proband
8%
MLH1
8%
Genetic Divergence
8%
Protease Inhibitor
8%
Single Nucleotide Polymorphism
8%
Gene Polymorphism
8%
Long Noncoding RNA
8%
Multidrug Resistance
8%
Disease Burden
8%
Blood Lipids
8%
N-Acetyltransferase 2
8%
Microsomal Epoxide Hydrolase
8%
Viral Clearance
8%
Virus Particle
8%
Keyphrases
SFRP1
18%
Pancreatic Adenocarcinoma
17%
Mwanza
16%
Promoter Methylation
16%
Intestinal Necrosis
16%
Pulmonary Tuberculosis
12%
Bisulfite Treatment
12%
Blood Biomarkers
11%
DNA Promoter Hypermethylation
11%
Diabetes
10%
Cell-free DNA (cfDNA)
10%
Optimal Well-being
10%
New Nordic Diet
10%
Meal Study
10%
Hepatitis B
9%
Antiviral Treatment
9%
Hepatitis C Virus Genotypes
9%
Gemcitabine
9%
MSH6 Gene
8%
Founder mutation
8%
2 Polymorphism
8%
Hepatitis C Prevalence
8%
Entecavir
8%
M184V mutation
8%
Tuberculosis Patients
8%
CD4 Lymphocytes
8%
Lymphocyte Dynamics
8%
Tuberculosis Treatment
8%
Mortality Prediction
8%
N-acetyltransferase 2 (NAT2)
8%
HIV Co-infection
8%
Soluble Epoxide Hydrolase
8%
Lipid Bodies
8%
Blood Lipids
8%
Benign Course
8%
Multidrug Resistance Protein 1 (MDR1)
8%
Diethylcarbamazine
8%
Virus Diseases
8%
Breast Cancer Resistance Protein
8%
Pegylated Interferon alfa-2a
8%
HCV RNA
8%
Diabetes Comorbidities
8%
Response Status
8%
Status Marker
8%
Iron Status
8%
Predictors of Physical Activity
8%
Epidemiological Survey
8%
Heart Rate Response
8%
Accelerometry
8%
Nucleos(t)ide Analogues
8%
